日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial

采用 CHOP 方案联合抗 CD20 疗法治疗滤泡性淋巴瘤:SWOG S0016 试验的 15 年随访

Shadman, Mazyar; LeBlanc, Michael; Rimsza, Lisa; Leonard, John P; Smith, Sonali M; Li, Hongli; Friedberg, Jonathan W

Interaction between reflected shock waves and laser-induced cavitation bubbles

反射冲击波与激光诱导空化气泡的相互作用

Dawoodian, Mazyar; Rezaee, Sasan; Barman, Dipanjan; El Moctar, Ould; Sainz, Rafael Manso; Mettin, Robert; Lechner, Christiane

An indirect comparison of zanubrutinib vs acalabrutinib plus venetoclax in patients with treatment-naive CLL

一项关于泽布替尼与阿卡替尼联合维奈托克治疗初治慢性淋巴细胞白血病患者的间接比较研究

Shadman, Mazyar; Tam, Constantine S; Brander, Danielle M; Lefebure, Marcus; Yang, Keri; Xu, Sheng; Tian, Tian; Kuptsova-Clarkson, Nataliya; Williams, Rhys; Hirata, Jamie; Munir, Talha

Zanubrutinib for the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studies

泽布替尼用于治疗伴有del(17p)和/或TP53 CLL/SLL的患者:临床研究分析

Tam, Constantine S; Anderson, Mary Ann; Šimkovič, Martin; Ghia, Paolo; Flinn, Ian W; Laribi, Kamel; Opat, Stephen; Cull, Gavin; Munir, Talha; Österborg, Anders; Tedeschi, Alessandra; Wang, Megan; Szeto, Andy; Allewelt, Heather; Salmi, Tommi; Li, Jessica; Xu, Linlin; Wu, Kenneth; Vezan, Remus; Shadman, Mazyar; Brown, Jennifer R

CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World Setting

利索卡巴吉内马拉鲁塞输注后2周以上发生细胞因子释放综合征(CRS)或免疫复合物相关神经病变(ICANS)的情况很少见:来自临床试验和真实世界的数据

Hunter, Bradley D; Lunning, Matthew; Shadman, Mazyar; Ahmed, Sairah; Abramson, Jeremy S; Perales, Miguel-Angel; Ahmed, Nausheen; Mirza, Abu-Sayeef; Isufi, Iris; Frigault, Matthew J; Crombie, Jennifer L; Miklos, David B; Vasconcelos, Alberto; Crotta, Alessandro; Bernasconi, David; Roy, Debasmita; Bleickardt, Eric; Pasquini, Marcelo C; Kamdar, Manali

Study protocol and pilot study results for a clinical intervention trial of PKU carriers and non-carriers: the Phe for Me trial

苯丙酮尿症携带者和非携带者临床干预试验的研究方案和试点研究结果:Phe for Me试验

Khan, Sophia M; Fennell, Madison L; Fallah, Mazyar; Jordan, Heather; Kroezen, Zachary; Britz-McKibbin, Philip; Millar, Philip J; Heister, Robyn R; Vohl, Marie-Claude; Keathley, Justine R

Wildland-urban interface co-combustion of biomass, synthetic polymeric materials, and lithium-ion batteries generates a new class of ultrafine soot-metal-PAH hybrid particles

生物质、合成聚合物材料和锂离子电池在荒野-城市交界处的共燃烧会产生一种新型的超细烟尘-金属-多环芳烃混合颗粒。

Rumi, Md Jalal Uddin; Wu, Yulin; Hossain, Md Jakir; Etemadzadeh, Mazyar; Zhang, Mengying; Kingston, Todd A; Li, Rui; Song, Guowen

The relationship between authenticity and suicidal ideation among medical university students in Iranshahr, southeastern Iran: a cross-sectional study

伊朗东南部伊兰沙赫尔市医科大学学生真实性与自杀意念的关系:一项横断面研究

Darban, Fatemeh; Heydarikhayat, Nastaran; Nadimi, Mazyar; Adelzadeh, Seyyed Reza

Time-Series Clustering Captures Patterns of Early Immune Effector Cell-Associated Hematotoxicity That Are Predictable Using Tree-Based Models

时间序列聚类捕捉到早期免疫效应细胞相关血液毒性的模式,这些模式可使用基于树的模型进行预测。

Liang, Emily C; Jeon, Yein; Qiao, Yang; Wu, Xiancheng; Huang, Jennifer J; Portuguese, Andrew J; Basom, Ryan; Torkelson, Aiko; Kirchmeier, Delaney; Braathen, Kristina; Cowan, Andrew J; Shadman, Mazyar; Hirayama, Alexandre V; Till, Brian G; Kimble, Erik L; Wu, Qian; Gauthier, Jordan

Number needed to treat to avoid progression and death and cost analysis: zanubrutinib versus acalabrutinib in relapsed/refractory chronic lymphocytic leukemia

为避免疾病进展和死亡而需要治疗的人数及成本分析:泽布替尼与阿卡替尼治疗复发/难治性慢性淋巴细胞白血病

Shadman, Mazyar; Chanan-Khan, Asher; Campbell, David; Xue, Mei; Massoudi, Marjan; Williams, Rhys; Yang, Keri; Tam, Constantine S